首页> 外文期刊>Endoscopy International Open >Double endoscopic bypass for gastric outlet obstruction and biliary obstruction
【24h】

Double endoscopic bypass for gastric outlet obstruction and biliary obstruction

机译:双内镜旁路治疗胃出口梗阻和胆道梗阻

获取原文
           

摘要

Background and study aims Double endoscopic bypass entails EUS-guided gastroenterostomy (EUS-GE) and EUS-guided biliary drainage (EUS-BD) in patients who present with gastric outlet and biliary obstruction. We report a multicenter experience with double endoscopic bypass. Patients and methods Retrospective, multicenter series involving 3 US centers. Patients who underwent double endoscopic bypass for malignant gastric and biliary obstruction from 1/2015 to 12/2016 were included. Primary outcome was clinical success defined as tolerance of oral intake and resolution of cholestasis. Secondary outcomes included technical success, re-interventions and adverse events (AE). Results Seven patients with pancreatic head cancer (57.1?% females; mean age 64.6?±?12.5 years) underwent double endoscopic bypass. Four patients had EUS-GE and EUS-BD performed during the same session with a mean procedure time of 70?±?20.4 minutes. EUS-GE and EUS-BD were technically successful in all patients, all of whom were able to tolerate oral intake with resolution of cholestasis in 6 (87.5?%). One patient had a repeat EUS-BD with normalization of bilirubin. There were no adverse events. Conclusions Double endoscopic bypass is feasible and effective when performed by experienced operators. Studies comparing this novel concept to existing techniques are warranted. Comment to this article: Endoscopy International Open – recently published Endoscopy 2017; 49(10): 1021-1021DOI: 10.1055/s-0043-119403
机译:背景和研究目的双重内窥镜旁路术对有胃出口和胆道梗阻的患者进行EUS引导的肠胃造口术(EUS-GE)和EUS引导的胆道引流(EUS-BD)。我们报告了双重内镜旁路多中心治疗的经验。患者和方法回顾性多中心研究,涉及3个美国中心。纳入从1/2015到12/2016接受双次内镜旁路手术治疗恶性胃和胆道梗阻的患者。主要结果是临床成功定义为口服摄入量的耐受性和胆汁淤积的缓解。次要结果包括技术成功,再次干预和不良事件(AE)。结果7例胰头癌患者(女性占57.1%,平均年龄64.6±12.5岁)接受了两次内镜旁路手术。四名患者在同一疗程中接受了EUS-GE和EUS-BD治疗,平均手术时间为70±±20.4分钟。在所有患者中,EUS-GE和EUS-BD在技术上均成功,所有患者均能够耐受口服摄入,胆汁淤积消退的比例为6(87.5%)。一名患者因胆红素正常化而再次进行EUS-BD。没有不良事件。结论由经验丰富的操作者进行双镜内镜旁路术是可行和有效的。必须将这种新颖概念与现有技术进行比较研究。对本文的评论:内窥镜国际公开赛–最近出版的《内窥镜检查2017》; 49(10):1021-1021DOI:10.1055 / s-0043-119403

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号